packageRimegepant

rimegepant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Rimegepant is a calcitonin gene-related peptide receptor antagonist used to treat acute migraine attacks in adults. It is an approved medicine and is authorised in the European Union for migraine.

Summary written by glm-5.3-flash from Wikidata Q27272184 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:rimegepant
ATC codes:N02CD06
DrugBank:DB12457
PubChem CID:51049968
Wikidata:Q27272184
formula:C28H28F2N6O3
molar mass:534.567 g/mol (PubChem CID 51049968)
logP:2.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown